NCT05272813 2024-07-18
A Study to Investigate the Efficacy and Safety of MS-553 in CLL/SLL
MingSight Pharmaceuticals, Inc
Phase 1/2 Terminated
Clinical Trials
3 trialsNCT00464113 2015-08-21
Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic Leukemia
Exelixis
Phase 1 Terminated
NCT00108108 2012-10-01
Dose-finding Trial of HCD122 in Patients With Chronic Lymphocytic Leukemia (CLL) That is Relapsed or Non-responsive to Prior Fludaribine Therapy
Novartis
Phase 1 Terminated